Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 1
Submit an article Journal homepage
2,201
Views
1
CrossRef citations to date
0
Altmetric
HPV

Safety and immunogenicity of a bivalent HPV16/18 vaccine in Chinese females

Li-Wei Shia Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information
,
Juan Lib Division of Respiratory Virus Vaccines, National Institute for Food and Drug Control, Beijing, ChinaView further author information
,
Bang-Wei Yuc Department of Regulatory and Medical Affairs, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, ChinaView further author information
,
Li-Rong Huanga Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information
,
Ke Lic Department of Regulatory and Medical Affairs, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, ChinaView further author information
,
Min Jic Department of Regulatory and Medical Affairs, Shanghai Zerun Biotechnology Co. Ltd, Shanghai, ChinaView further author information
,
Ling-Yun Zhoud Quality Research Department, Shanghai Zerun Biotechnology Co., Ltd, Shanghai, ChinaView further author information
,
Lin Yuane Department of Regulatory and Medical Affairs, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, ChinaView further author information
,
Shu-Yuan Yange Department of Regulatory and Medical Affairs, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, ChinaView further author information
,
Jing-Jing Chene Department of Regulatory and Medical Affairs, Walvax Biotechnology Co. Ltd, Kunming, Yunnan, ChinaView further author information
,
Ling Wangg Department of Health Statistics, Air Force Military Medical University, Xi’an, Shanxi, ChinaView further author information
,
Zhi-Wei Jiangf Department of Health Statistics, Beijing Key Tech Statistical Technology Co. Ltd, Beijing, ChinaView further author information
,
Rong-Cheng Lia Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information
,
Yan-Ping Lia Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaView further author information
,
Jie-Lai Xiag Department of Health Statistics, Air Force Military Medical University, Xi’an, Shanxi, ChinaCorrespondence[email protected]
View further author information
,
Zhao-Jun Moa Institute of Vaccine Clinical Research, Guangxi Center for Disease Control and Prevention, Nanning, Guangxi, ChinaCorrespondence[email protected]
View further author information
&
Chang-Gui Lib Division of Respiratory Virus Vaccines, National Institute for Food and Drug Control, Beijing, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2209001 | Received 28 Feb 2023, Accepted 27 Apr 2023, Published online: 30 May 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.